| Hans-Günter Meyer-Thompson | Covid-19
An Indigenous-led buprenorphine-naloxone treatment program to address opioid use in remote Northern Canada.
An Indigenous-led buprenorphine-naloxone treatment program to address opioid use in remote Northern Canada.
Zuk AM, Ahmed F, Charania NA, Sutherland C, Kataquapit G, Moriarity RJ, Spence ND, Tsuji LJS, Liberda EN.
Health. 2024 Sep 1;5:100190. doi: 10.1016/j.dialog.2024.100190. PMID: 39296322; PMCID: PMC11408382.